Recalls: FDA Reports Salmonella Contamination In More Kratom Supplements
This article was originally published in The Rose Sheet
Executive Summary
FDA's list of recalls of health, beauty and wellness products that have been categories from April 25 through June 20 include products from nine other kratom supplement marketers. Drug-spiked products marketed as supplements also are included in FDA's list for the period.
You may also be interested in...
Kratom Group Contests FDA's Opioid Finding, Requests Joint Meeting With NIDA
American Kratom Association accuses FDA of using “inaccurate, extrapolated and distorted” information on adverse events and deaths allegedly associated with the use of kratom to justify scheduling it as a controlled substance. After FDA Commissioner Gottlieb says the criticism is unfounded and kratom has no future as a dietary ingredient in the US, the group asks for joint meeting with NIDA to discuss "public health policy that allows for consumers to safely use natural kratom."
Las Vegas Kratom Marketer Rolls Dice On FDA's Mandatory Recall Authority
FDA for the first time exercises its mandatory recall authority over food and supplement products to order Triangle Pharmanaturals, which opened for business in Las Vegas in April 2017, to recall all of the kratom-containing products it has distributed and to cease distributing additional products.The agency also notes in the announcement that it continues to scrutinize kratom's safety unrelated to contamination.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”